Eva Přáda’s path in biophysical chemistry and the future of pharmaceutical research
From Cambridge labs to groundbreaking research in Vienna, Eva Přáda is a Czech biophysical chemist using science to address everyday problems. In the latest episode of Science Without Borders, discover how her international journey, powered by top scholarships and global collaborations, is influencing the future of pharmaceutical research.
Eva Přáda is a biophysical chemist whose work bridges the gap between academic research and real-world pharmaceutical development. Thanks to scholarships from the Bakala Foundation and the Krsek Foundation, she pursued her PhD at the University of Cambridge, where she collaborated with companies like AstraZeneca on peptide-based drugs used in diabetes and obesity treatment. Today, as a postdoctoral researcher at TU Wien, she focuses on enzyme production and protein refolding—processes that are key to making biologically active drugs both stable and effective.
But for Eva, science is not only about molecules. It’s also about opportunity—about learning how to solve problems, work independently, and build international collaborations. While she enjoys working in Vienna, she’s open to returning to Czechia to contribute her skills and experience to local research.
Watch this new video series by Radio Prague International and the Czech Centre Vienna in cooperation with Czexpats in Science.
Related
-
Science without Borders: Interviews with young scientists who are helping to change the world
They are young, ambitious and above all curious. They left their home country to study science abroad. The spotlight is on Czech scientists working in Austria.
Latest
-
Strahov Library: Baroque gem ranked among the most beautiful in the world
The Strahov Library is one of the oldest and best preserved libraries in Czechia. According to Tatler magazine it is one of the ten most beautiful libraries in the world.
-
Turning research into real therapy: Veronika Verdonckt Smutná on science inside the private sector
A scientific career can take on many forms. For Veronika Smutná, it was a transition from public research to clinical development in the private pharmaceutical sphere.
-
Karel Břinda on research at Harvard and working with bacteria as if they were books
Karel Břinda sheds light on how curiosity, mobility, and interdisciplinarity can shape a modern researcher’s path in a world where science increasingly transcends borders.
-
Kateřina Jeřábková-Roda on tracking cancer’s aggression and the future of early diagnostics
Kateřina Jeřábková-Roda is involved in cancer research that links microscopic cellular changes to the hope of earlier diagnosis and better patient outcomes.
-
Anticipating accidents: Petr Dobiáš’s vision for smarter elderly care
An aging population is one of the biggest challenges facing modern society. Petr Dobiáš explains how computer science and AI can help respond to it.
-
Passion for proteins: Štěpánka Nedvědová on a quest to curb viral replication
In this first instalment of Radio Prague International’s brand new edition of Science without Borders, Štěpánka Nedvědová sheds light on the work of a molecular scientist.
Pages
- « první
- ‹ předchozí
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- …
- následující ›
- poslední »
